NCT00002328已完成不适用
Oral/Intravenous Azithromycin in the Treatment of Cryptosporidiosis in Patients Whose Disease Has Not Been Controlled by Conventional Therapy
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- Pfizer
- 试验地点
- 2
研究概览
简要总结
To provide azithromycin for the treatment of individual patients with proven cryptosporidiosis whose disease has persisted or progressed despite prior therapies.
研究设计
- 研究类型
- Interventional
- 主要目的
- Treatment
入排标准
- 年龄范围
- 1 Day 至 —（Child, Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
研究者
研究点 (2)
Loading locations...
相似试验
已完成
不适用
Azithromycin in the Treatment of Cryptosporidiosis in Patients With Acquired Immune Deficiency Syndrome (AIDS): A Randomized, Multi-Center, Placebo-Controlled, Double-Blind StudyHIV InfectionsCryptosporidiosisNCT00002082Pfizer
已完成
3 期
Benefits of systemically administered adjunctive azithromycin with non-surgical periodontal therapy in treating advanced gum disease.Stage III and IV, grade C periodontitisOral and Gastrointestinal - Other diseases of the mouth, teeth, oesophagus, digestive system including liver and colonACTRN12619000560190School of Dentistry, University of Queensland56
已完成
不适用
Efficacy of Azithromycin as an Adjunct to Non-Surgical Periodontal TreatmentPeriodontitisNCT03629288Universidad Nacional Andres Bello18
已完成
2 期
Azithromycin Combination Therapy for the Treatment of Uncomplicated Falciparum Malaria in BangladeshUncomplicated Falciparum MalariaNCT00356005Medical University of Vienna228
进行中（未招募）
1 期
Personalized antibiotic therapy in combination with standard therapy to achieve a fecal profile associated with prolonged complaint-free period in pediatric Crohn’s DiseaseCrohn's DiseaseEUCTR2019-004219-29-NLAmsterdam UMC20